Hongwei Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Hongwei Ding has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Erdong Shen
Department of Oncology, the First People’s Hospital of YueYang, YueYang, P.R. China
1 shared publication - Huiyun Huang
Dermatological Department, the First People’s Hospital of YueYang, YueYang, P.R. China
1 shared publication - Qiang Wang
Dermatological Department, the First People’s Hospital of YueYang, YueYang, P.R. China
1 shared publication - Shiqing Tang
Dermatological Department, the First People’s Hospital of YueYang, YueYang, P.R. China
1 shared publication - Xingyou Tan
Dermatological Department, the First People’s Hospital of YueYang, YueYang, P.R. China
1 shared publication - Xiuli Guo
Dermatological Department, the First People’s Hospital of YueYang, YueYang, P.R. China
1 shared publication
Latest Publications
- Open Access
- 16 May 2015
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 14 (1) , 1-9
Increased serum resistin levels correlate with psoriasis: a meta-analysis
Recent studies implicate adipokines in the pathogenesis of inflammatory diseases, including psoriasis. In this study we evaluated the significance of serum resistin levels in psoriasis patients using a meta-analysis approach.223 Relevant articles were retrieved by searching the following English and Chinese databases: Cochrane Library, PubMed, Springer Link, Chinese Biomedical Database (CBM) and Chinese National Knowledge Infrastructure (CNKI). The retrieved studies were subjected to a thorough screening procedure to identify case–control studies that contained the required data. Data was extracted from each study and Version 12.0 STATA statistical software was employed for statistical analyses. Nine case–control studies, containing 421 psoriasis patients and 348 healthy controls, were included in this study. The major result of the meta-analysis revealed a statistically significant association between serum resistin levels and psoriasis (SMD = 2.22, 95%CI: 1.14-3.29, P < 0.001). Subgroup analysis based on ethnicity showed that, compared to the healthy controls, serum resistin levels were markedly higher in psoriasis patients in both Asian and Caucasian populations (Asians: SMD = 3.27, 95%CI = 1.62 ~ 4.91, P < 0.001; Caucasians: SMD = 0.91, 95%CI = 0.28 ~ 1.54, P < 0.001). Based on our results, we conclude that serum resistin level in psoriasis patients is higher than healthy controls, and raises the possibility that elevated serum resistin levels may be a novel diagnostic marker in psoriasis and may predict the occurrence of co-morbidities in psoriasis patients.
- 16 May 2015
- Published by Springer Nature in Lipids in Health and Disease
- Vol. 14 (1) , 1-9
Open AccessIncreased serum resistin levels correlate with psoriasis: a meta-analysis
Recent studies implicate adipokines in the pathogenesis of inflammatory diseases, including psoriasis. In this study we evaluated the significance of serum resistin levels in psoriasis patients using a meta-analysis approach.223 Relevant articles were retrieved by searching the following English and Chinese databases: Cochrane Library, PubMed, Springer Link, Chinese Biomedical Database (CBM) and Chinese National Knowledge Infrastructure (CNKI). The retrieved studies were subjected to a thorough screening procedure to identify case–control studies that contained the required data. Data was extracted from each study and Version 12.0 STATA statistical software was employed for statistical analyses. Nine case–control studies, containing 421 psoriasis patients and 348 healthy controls, were included in this study. The major result of the meta-analysis revealed a statistically significant association between serum resistin levels and psoriasis (SMD = 2.22, 95%CI: 1.14-3.29, P < 0.001). Subgroup analysis based on ethnicity showed that, compared to the healthy controls, serum resistin levels were markedly higher in psoriasis patients in both Asian and Caucasian populations (Asians: SMD = 3.27, 95%CI = 1.62 ~ 4.91, P < 0.001; Caucasians: SMD = 0.91, 95%CI = 0.28 ~ 1.54, P < 0.001). Based on our results, we conclude that serum resistin level in psoriasis patients is higher than healthy controls, and raises the possibility that elevated serum resistin levels may be a novel diagnostic marker in psoriasis and may predict the occurrence of co-morbidities in psoriasis patients.